IVOS Medical Named as Finalist in Inaugural Space Challenge to Advance the Future of Space Health 

Aug 5, 2022 | Press Release

Irvine, CA – August 5, 2022, – IVOS Medical, Inc., a startup medical device company in airway management, today announced that its innovative BOSS G4™ video laryngoscope sheath has been selected as a finalist in the Inaugural Care in Space Challenge Pitch Summer 2022 held at UCLA. Under development, the IVOS BOSS G4 is an economical, disposable video laryngoscope sheath that incorporates novel features to help maintain clear vision during intubation and increase first-pass success in emergency, soiled intubations.

Finalists were selected by aerospace, bioscience, and bio/MedTech industry experts who assessed entrepreneurial acumen, scientific merit, business model viability, and overall feasibility.  

About the Space Challenge

Hosted by Boryung in collaboration with Axiom Space and Starburst Aerospace, the CIS Challenge aims to advance the future of space health and the next generation of pharmaceutical, bioscience, and medtech development in space. The first of its kind, the program is positioned to accelerate the development of space health and health-adjacent solutions to increase access to space, solve human healthcare-related problems in space, and create novel healthcare solutions in space for terrestrial use.

About IVOS Medical
IVOS Medical is a medical device company committed to advancing airway management technology, particularly for challenging intubations. Its flagship product, the patent-pending Breathing Optimization and Suction System (BOSS™) G4™, enhances critical intubation success through video laryngoscopy. IVOS Medical is dedicated to developing and elevating intubation tools with the goal of improving patient safety and healthcare efficiency. For more information, visit www.ivosmedical.com.

###

Obstructed Vision in Soiled Airways

0-11 sec:

The initial insertion of the video laryngoscope resulted in obstruction of the camera view due to fluids in the oral cavity. The device was removed from the mouth, and the lens was manually cleaned to restore the camera to baseline functionality before being reinserted.

12-21 sec:

Once the video laryngoscope was reinserted into the oral cavity, critical time had already been lost, as the simulated patient remained apneic and gastric fluids continued to enter the lungs.

22-30 sec:

A Cormack-Lehane grade 1 view was achieved after aggressive suctioning with a Yankauer suction catheter. This provided clear visualization for the healthcare provider to insert the endotracheal tube using indirect visualization.

Obstructed Vision in Soiled Airways

0-13 sec:

The video laryngoscope is equipped with the IVOS BOSS G4™ system. The device integrates gas flow into the handle to continuously provide a clear camera window throughout the entire intubation process, without requiring removal of the device from the patient’s mouth.

14-27 sec:

The G4’s integrated suction channel removes oral cavity fluids and reduces the potential for aspirate to enter the lungs. Maintaining a clear view of the airway in an emergency setting can increase first-pass success, thereby reducing morbidity and mortality in patients.

28-37 sec:

The patient remains apneic for only a minimal amount of time while the healthcare provider inserts the endotracheal tube into the trachea and secures the airway for lifesaving ventilation.